Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Cooper

Showing results (91-100 of 175) with videos related to

Pageof 18
Sort By:
Springer Seminars in Immunopathology|January 1, 1983
Methods to detect and quantitate complement activationN R Cooper, G R Nemerow, J T Mayes
Journal of Virology|May 1, 1986
Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified proteinG R Nemerow, M F Siaw, N R Cooper
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1979
Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertaseA T Sobel, N R Cooper, R D Schreiber
The Journal of Experimental Medicine|August 1, 1974
Formation and biologic role of polyoma virus-antibody complexes. A critical role for complementM B Oldstone, N R Cooper, D L Larson
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1979
Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab')2 and Fab' fragmentsJ G Sissons, N R Cooper, M B Oldstone
The Journal of General Virology|December 1, 1996
Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infectionM L Roberts, A T Luxembourg, N R Cooper
The Journal of Clinical Investigation|March 1, 1975
Studies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edemaP C Harpel, T E Hugli, N R Cooper
The Journal of Biological Chemistry|May 15, 2001
Characterization of a novel proapoptotic caspase-2- and caspase-9-binding proteinE Bonfoco, E Li, F Kolbinger, et al.
The Journal of Clinical Investigation|November 1, 1982
Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complementG R Nemerow, F C Jensen, N R Cooper
The Journal of Experimental Medicine|August 4, 1998
Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptideB M Bradt, W P Kolb, N R Cooper
Pageof 18

Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
Springer Seminars in Immunopathology|January 1, 1983
Methods to detect and quantitate complement activationN R Cooper, G R Nemerow, J T Mayes
Journal of Virology|May 1, 1986
Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified proteinG R Nemerow, M F Siaw, N R Cooper
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1979
Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertaseA T Sobel, N R Cooper, R D Schreiber
The Journal of Experimental Medicine|August 1, 1974
Formation and biologic role of polyoma virus-antibody complexes. A critical role for complementM B Oldstone, N R Cooper, D L Larson
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1979
Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab')2 and Fab' fragmentsJ G Sissons, N R Cooper, M B Oldstone
The Journal of General Virology|December 1, 1996
Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infectionM L Roberts, A T Luxembourg, N R Cooper
The Journal of Clinical Investigation|March 1, 1975
Studies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edemaP C Harpel, T E Hugli, N R Cooper
The Journal of Biological Chemistry|May 15, 2001
Characterization of a novel proapoptotic caspase-2- and caspase-9-binding proteinE Bonfoco, E Li, F Kolbinger, et al.
The Journal of Clinical Investigation|November 1, 1982
Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complementG R Nemerow, F C Jensen, N R Cooper
The Journal of Experimental Medicine|August 4, 1998
Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptideB M Bradt, W P Kolb, N R Cooper
Pageof 18